A Subjective Evaluation of the Effects of a Probiotic Formulation on Skin Quality in Young Adult Females: Open-Label Proof-of-Concept Study
International Journal of Probiotics & Prebiotics · 2025
DOI: 10.37290/ijpp.v1i1.5 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Probiotics & Prebiotics, 2025. Verfasst von Ola Kassem.
Abstract (Originalsprache)
This pilot, proof-of-concept, study was designed to assess the effect of a blend of Lactobacillus helveticus Rosell®-52 and Bifidobacterium longum Rosell®-175 on parameters of skin quality. Capsules containing L. helveticus Rosell®-52 and B. longum Rosell®-175 were given to 35 healthy women (3 billion CFU/d for 56 days), and assessments of skin quality were performed at baseline, as well as on days 28 and 56. Importantly, the formulation significantly reduced the appearance of fine lines and improved skin firmness, elasticity, and hydration. In addition, study participants experienced improvements in sleep quality and felt less stressed (PSS-10 subjective stress questionnaire). Taken together, these results provide the rationale to conduct a larger, placebo-controlled trial and to assess the effects of the oral probiotic intake in healthy women with more visible signs of skin aging.
Zitieren
APA
Kassem, O. (2025). A Subjective Evaluation of the Effects of a Probiotic Formulation on Skin Quality in Young Adult Females: Open-Label Proof-of-Concept Study. International Journal of Probiotics & Prebiotics. https://doi.org/10.37290/ijpp.v1i1.5
Vancouver
Kassem O. A Subjective Evaluation of the Effects of a Probiotic Formulation on Skin Quality in Young Adult Females: Open-Label Proof-of-Concept Study. International Journal of Probiotics & Prebiotics. 2025. doi:10.37290/ijpp.v1i1.5
BibTeX
@article{Kassem2025,
author = {Kassem, Ola},
title = {A Subjective Evaluation of the Effects of a Probiotic Formulation on Skin Quality in Young Adult Females: Open-Label Proof-of-Concept Study},
journal = {International Journal of Probiotics & Prebiotics},
year = {2025},
doi = {10.37290/ijpp.v1i1.5}
}
EUVIMED